Vaikom Mahadevan to Transcatheter Aortic Valve Replacement
This is a "connection" page, showing publications Vaikom Mahadevan has written about Transcatheter Aortic Valve Replacement.
Connection Strength
2.550
-
Melo D, Agrawal H, Parikh DS, Sarwary S, Lin S, Choy HH, Mallawaarachchi I, Kallianos K, Hope M, Mahadevan VS. Accuracy of Ferumoxytol-Enhanced MRA-Guided TAVR in Patients With Chronic Kidney Disease. JACC Cardiovasc Interv. 2022 03 28; 15(6):677-679.
Score: 0.655
-
Caughron H, Parikh D, Allison Z, Deuse T, Mahadevan VS. Outcomes of transcatheter aortic valve replacement in end stage liver and renal disease. Catheter Cardiovasc Interv. 2021 07 01; 98(1):159-167.
Score: 0.606
-
Judson GL, Agrawal H, Mahadevan VS. Conduction System Abnormalities After Transcatheter Aortic Valve Replacement: Mechanism, Prediction, and Management. Interv Cardiol Clin. 2019 10; 8(4):403-409.
Score: 0.544
-
Singh SP, Agrawal H, Eichler CM, Mahadevan VS. Percutaneous exclusion of post-transcatheter aortic valve replacement (TAVR) induced aortic pseudoaneurysm using an Amplatzer Vascular Plug 2 (AVP2). BMJ Case Rep. 2019 Jul 02; 12(7).
Score: 0.541
-
Krishna MM, Joseph M, Ezenna C, Pereira V, Rossi R, Akman Z, Rubens M, Mahadevan VS, Nanna MG, Goldsweig AM. TAVR vs. SAVR for severe aortic stenosis in the low and intermediate surgical risk population: An updated meta-analysis, meta-regression, and trial sequential analysis. Cardiovasc Revasc Med. 2025 Oct; 79:78-89.
Score: 0.204